AB-452
AB-452, a Dihydroquinolizinone (DHQ) analogue, is a potent and orally active HBV RNA destabilizer. AB-452 inhibits PAPD5/7 proteins in vitro with good in vivo efficacy in a chronic HBV mouse model.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2226178-35-2
- Fòrmula: C21H26N2O6
- Peso molecular:402.44
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Hepatocyte | EC50 |
3 nM
Compound: (S)-20; AB-452
|
Antiviral activity against AAV-Hepatitis B virus infected in human Primary hepatocyte assessed as reduction in HBeAg level measured after 16 days by ELISA
Antiviral activity against AAV-Hepatitis B virus infected in human Primary hepatocyte assessed as reduction in HBeAg level measured after 16 days by ELISA
|
[PMID: 38190324] |
| Hepatocyte | EC50 |
3 nM
Compound: (S)-20; AB-452
|
Antiviral activity against AAV-Hepatitis B virus infected in human Primary hepatocyte assessed as reduction in HBsAg level measured after 16 days by ELISA
Antiviral activity against AAV-Hepatitis B virus infected in human Primary hepatocyte assessed as reduction in HBsAg level measured after 16 days by ELISA
|
[PMID: 38190324] |
| Hepatocyte | EC50 |
3 nM
Compound: (S)-20; AB-452
|
Antiviral activity against AAV-Hepatitis B virus infected in human Primary hepatocyte assessed as reduction in HBV DNA level measured after 16 days by ELISA
Antiviral activity against AAV-Hepatitis B virus infected in human Primary hepatocyte assessed as reduction in HBV DNA level measured after 16 days by ELISA
|
[PMID: 38190324] |
| HepG2 2.2.15 | CC50 |
>50 μM
Compound: (S)-20; AB-452
|
Cytotoxicity against human HepG2.2.15 cells by Cell-titer Glo luminescent assay
Cytotoxicity against human HepG2.2.15 cells by Cell-titer Glo luminescent assay
|
[PMID: 38190324] |
| HepG2 2.2.15 | EC50 |
0.001 μM
Compound: (S)-20; AB-452
|
Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of HBsAg level incubated for 6 days by microplate-based chemiluminescence immunoassay
Antiviral activity against HBV infected in human HepG2.2.15 cells assessed as inhibition of HBsAg level incubated for 6 days by microplate-based chemiluminescence immunoassay
|
[PMID: 38190324] |
Chemical Information
-
No. CAS 2226178-35-2
-
Peso molecular 402.44
-
Fòrmula C21H26N2O6
-
SMILES
CC([C@H]1N2C(C3=NC(OC)=C(OCCCOC)C=C3C1)=CC(C(C(O)=O)=C2)=O)C
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)